Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
57.1%
% of PBE's 28 holdings also in FBT
53.3%
% of FBT's 31 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 5.1% | 4.3% | 4.3% |
|
GILEAD SCIENCES INC | 5.1% | 3.6% | 3.6% |
|
INCYTE CORP | 4.7% | 3.5% | 3.5% |
|
UNITED THERAPEUTICS CORP | 5.0% | 3.4% | 3.4% |
|
ILLUMINA INC | 5.1% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to FBT
|
VERACYTE INC | 2.9% |
|
BIOCRYST PHARMACEUTICALS INC | 2.9% |
|
BIO-TECHNE CORPORATION | 2.8% |
|
BLUEPRINT MEDICINES CORP. | 2.7% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.7% |
|
CAREDX, INC. | 2.6% |
|
ROYALTY PHARMA PLC CLASS A | 2.6% |
|
TG THERAPEUTICS INC | 2.6% |
|
AXSOME THERAPEUTICS, INC. | 2.6% |
|
XENCOR INC | 2.6% |
PBE Underweight Relative to FBT
|
CORCEPT THERAPEUTICS INC | -4.1% |
 |
ARGENX SE ADR | -3.8% |
|
REPLIGEN CORP | -3.8% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
WATERS CORP | -3.6% |
 |
ALKERMES PLC | -3.6% |
 |
BIONTECH SE SPONSORED ADR | -3.4% |
|
VERTEX PHARMACEUTICALS INC | -3.2% |
|
BRUKER CORP | -3.0% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.0% |